avapro and Anemia
avapro has been researched along with Anemia in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " Risk factors for diabetic nephropathy are discussed, and include hyperglycemia, hypertension, angiotensin II, proteinuria, dyslipidemia, smoking, and anemia." | 4.82 | Outcome studies in diabetic nephropathy. ( Mohanram, A; Toto, RD, 2003) |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ghali, JK | 1 |
| Mohanram, A | 1 |
| Toto, RD | 1 |
| Simonetti, GD | 1 |
| Bianchetti, MG | 1 |
| Konrad, M | 1 |
| von Vigier, RO | 1 |
| Schwarzbeck, A | 1 |
| Wittenmeier, KW | 1 |
| Hällfritzsch, U | 1 |
Reviews
1 review available for avapro and Anemia
| Article | Year |
|---|---|
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme | 2003 |
Other Studies
3 other studies available for avapro and Anemia
| Article | Year |
|---|---|
Irbesartan for heart failure with preserved ejection fraction.
Topics: Anemia; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Creatinine; Heart Failure; Hosp | 2009 |
Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
Topics: Anemia; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Child; Erythropoietin; Hemoglob | 2007 |
Anaemia in dialysis patients as a side-effect of sartanes.
Topics: Anemia; Antihypertensive Agents; Biphenyl Compounds; Hemoglobins; Humans; Irbesartan; Kidney Transpl | 1998 |